Sinusoidal obstruction syndrome/veno-occlusive disease complication in lymphoma patients treated with oxaliplatin-based regimen: A case series report

Coppell, 2010, Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course and outcome, Biol Blood Marrow Transplant, 16, 157, 10.1016/j.bbmt.2009.08.024 Mohty, 2016, Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation, Bone Marrow Transplant, 51, 906, 10.1038/bmt.2016.130 Kuhnowski, 2007, Syndrome d’obstruction sinusoïdale (maladie veino-occlusive), Reanimation, 16, 626, 10.1016/j.reaurg.2007.08.002 Fan, 2014, Sinusoidal obstruction syndrome (hepatic veno-occlusive disease), J Clin Exp Hepatol, 4, 332, 10.1016/j.jceh.2014.10.002 Carreras, 2007, Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients, Biol Blood Marrow Transplant, 13, 1448, 10.1016/j.bbmt.2007.08.002 Carreras, 2011, The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade, Biol Blood Marrow Transplant, 17, 1713, 10.1016/j.bbmt.2011.06.006 Cheson, 2014, Recommendations for initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification, J Clin Oncol, 32, 3059, 10.1200/JCO.2013.54.8800 Tixier, 2016, Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients, Hematol Oncol Rigacci, 2010, Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma, Cancer, 116, 4573, 10.1002/cncr.25216 Lignon, 2010, Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma, Clin Lymphoma Myeloma Leuk, 10, 262, 10.3816/CLML.2010.n.055 Rubbia-Brandt, 2004, Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer, Ann. Oncol, 15, 460, 10.1093/annonc/mdh095 Morine, 2014, Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis, Hepatol Res, 44, 59, 10.1111/hepr.12107 Aloia, 2006, Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases, J Clin Oncol, 24, 4983, 10.1200/JCO.2006.05.8156 Vauthey, 2006, Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases, J Clin Oncol, 24, 2065, 10.1200/JCO.2005.05.3074 Zorzi, 2007, Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases, Br J Surg, 94, 274, 10.1002/bjs.5719 Nakano, 2008, Sinusoidal injury increases morbidity after major hepatotectomy in patients with colorectal liver metastases receiving preoperative chemotherapy, Ann Surg, 247, 118, 10.1097/SLA.0b013e31815774de Duwe, 2017, Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection, Eur J Surg Oncol, 10.1016/j.ejso.2017.05.008 Robinson, 2012, Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis, Ann Surg Oncol, 19, 4287, 10.1245/s10434-012-2438-8